Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

04-17

InnoModels Biotechnology: Immune Co-Culture Killing Models

With the continuous development of biological science and medical technology, human understanding of diseases and treatment modalities are gradually deepening. Among them, immunotherapy, as an emerging therapeutic modality, has shown great potential in fields such as cancer. However, the mechanism of immunotherapy is complex, and how to accurately simulate the immune response process in the body has been a challenge for researchers. For this reason, InnoModels Biotechnology has developed a new 3D immune co-culture killing model, which aims to more realistically simulate the interaction between immune cells and tumor cells in the body, providing a more accurate tool for immunotherapy research.

04-16

InnoModels Biotechnology：3D Organoid Platform Function Introduction

With the rapid development of biotechnology, 3D organoid technology has gradually emerged as a new favorite in biomedical research. In this field, the 3D organoid platform of InnoModels Biotechnology has opened the door to real human physiology and disease mechanisms for researchers with its excellent key functions.

04-16

InnoModels' In Vitro Killing Experimental Platform: An Innovative Tool to Uncover the Mechanisms of Cytotoxicity

With the further development of biomedicine, the study of cytotoxicity mechanism has become more and more important. In this field, the in vitro killing experiment platform of InnoModels has become an innovative tool to reveal the mechanism of cytotoxicity by virtue of its unique features

04-12

InnoModels Biotechnology: Unique Features of the CDX Modeling Platform

In the field of biomedicine, tumor research has always been a key area pursued by researchers. In order to more accurately and deeply study the occurrence, development and treatment process of tumors, many research institutions and enterprises are exploring and improving various experimental models. The CDX model platform launched by InnoModels Biotechnology, with its unique features, is leading the new direction of tumor research

< 1...28 29 30...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License